Neuromyelitis Optica (Devic’s Syndrome) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 43 pages | ID: NC3C91215A7EN
VPAResearch

Abstracts

Neuromyelitis Optica (Devic’s Syndrome) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Neuromyelitis Optica (Devic’s Syndrome) disease clinical trials. The research work analyzes the ongoing Neuromyelitis Optica (Devic’s Syndrome) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Neuromyelitis Optica (Devic’s Syndrome) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Neuromyelitis Optica (Devic’s Syndrome) clinical trials.

Scope of the Report-

• Ongoing Neuromyelitis Optica (Devic’s Syndrome) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Neuromyelitis Optica (Devic’s Syndrome)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Neuromyelitis Optica (Devic’s Syndrome) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Neuromyelitis Optica (Devic’s Syndrome) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials by Phase
3.2 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials by Type
3.3 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials
4.2 Top 10 Countries conducting Neuromyelitis Optica (Devic’s Syndrome) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials by Sponsor Type
5.2 Neuromyelitis Optica (Devic’s Syndrome) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Neuromyelitis Optica (Devic’s Syndrome) Trials by year
6.2 Subjects Recruited for Neuromyelitis Optica (Devic’s Syndrome) Trials by Phase
6.3 Subjects Recruited for Neuromyelitis Optica (Devic’s Syndrome) Trials by Trial Type
6.4 Subjects Recruited for Neuromyelitis Optica (Devic’s Syndrome) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase
7.2 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase
7.3 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase
7.4 Ongoing Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Country
Figure 2: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Phase of Development, 2018
Figure 3: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Status, 2018
Figure 4: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Type, 2018
Figure 5: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials Split by Region, 2000-2018
Figure 6: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Type of Economy, 2018
Figure 7: Neuromyelitis Optica (Devic’s Syndrome)- Enrolment by Phase, 2018
Figure 8: Neuromyelitis Optica (Devic’s Syndrome)- Enrolment by Trial Type, 2018
Figure 9: Neuromyelitis Optica (Devic’s Syndrome)- Enrolment by Recruitment Status, 2018
Figure 10: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Sponsor Type, 2018
Figure 11: Neuromyelitis Optica (Devic’s Syndrome)- Enrolment by Type of Sponsors
Figure 12: Neuromyelitis Optica (Devic’s Syndrome)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Sponsor Type, 2018
Table 2: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Economy Type, 2018
Table 3: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials by Region, 2018
Table 4: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Neuromyelitis Optica (Devic’s Syndrome)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Neuromyelitis Optica (Devic’s Syndrome)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Neuromyelitis Optica (Devic’s Syndrome)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Neuromyelitis Optica (Devic’s Syndrome)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Neuromyelitis Optica (Devic’s Syndrome)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company